Medical Cannabis

Separate efforts to remove the medical cannabis program and legalize recreational cannabis in South Dakota are proposed to appear on the 2024 ballot.

Let’s meet CSC Fall speaker Nurse Laura Barrett-Nutting, Executive Director of the National Clinical Directors Consortium and Owner of Ask Nurse Laura.

In this Deep Dive interview, Dr. Peter Grinspoon, a keynote speaker at the Cannabis Science Conference Fall, shares his views on cannabis policies, insights from his latest book, and what he hopes to see in the future of medical cannabis.

Let’s meet Cannabis Science Conference Fall speaker Dr. Travis Poonai, a pharmacist with a specialty in medical cannabis.

Let’s meet Cannabis Science Conference Fall speaker Dawn-Marie Steenstra, a Clinical Director of Dispensaries in Maryland, and a founder for the National Clinical Director Consortium.

See the program overview for the upcoming Cannabis Science Conference Fall in Providence, Rhode Island September 20-22nd.

The seventh installment in the series looks at cannabis use in people over 50 years old, the stigma surrounding cannabis use, and the concept of ‘plants over pills.’

The chairman of Alabama’s Medical Cannabis Commission (AMCC), Dr. Steve Stokes, has resigned from his position.

Dr. Peter Grinspoon, a primary care doctor at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and a 25-year cannabis specialist, will be a keynote speaker at the upcoming Cannabis Science Conference Fall taking place September 21-22, 2023 in Providence, Rhode Island. Here, Dr. Grinspoon shares his background and interest in medical cannabis as well as some policies he’d like to see changed in the future.

A recent study revealed how medical cannabis improves military veterans’ quality of life and helped reduce prescription drug use.

Americans for Safe Access, the nation’s largest member-based organization promoting safe access to medical cannabis, recently released a detailed report on how disparities in state cannabis testing programs affect the health of patients.

Pharmaceutical developer Oxford Cannabinoid Technologies recently described the potential of its latest cannabinoid-based immunotherapy treatment.

North Carolina State House Speaker, Tim Moore, announced that a medical cannabis legalization bill which would have benefitted many, such as veterans, is unlikely to pass in 2023.

Our sister publication, CURE, recently spoke with Kim Stuck, breast cancer survivor and author of our blog Stuck on Compliance.

New Hampshire allows out-of-state visitors, including those from Canada, to buy medical cannabis.

Arkansas medical cannabis retailers reported increased product volume and sales within the first 6 months of the year.

Recent activity in the Senate focuses on both recreational and medical cannabis regulations and reforms.

A Brazilian university has detected cannabidiol (CBD) in a native plant called Trema micrantha blume.

Cannabis Science Conference Spring was held in Portland, Oregon from April 19-21, 2023. Here we provide a few highlights from the event.

The webinar "Cannabis and Dementia: Unlocking the Potential" was held on June 14, 2023, and featured four panelists’ experiences treating dementia symptoms with cannabis.

If approved, the newly licensed facilities will have 120 days to open their doors. More applications are anticipated in the future.

Dustin Sulak, DO, founder of Healer and Integr8 Health, served as one of the keynote speakers at Cannabis Science Conference Spring 2023.

What is Cherissa Jackson, RN most excited about as the medical track program chair for Cannabis Science Conference?

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.

The House and Senate introduced a revised bill to mandate Veterans Affairs (VA) to conduct research on the effects of medical cannabis on veterans with post-traumatic stress disorder (PTSD) and chronic pain.

A major focus area when it comes to medical cannabis is patient and healthcare education, or rather the lack of that education and rampant misinformation. When Megan Mbengue, BSN, RN, CHPN, saw this gap in educational resources firsthand for people who are looking to use cannabis as a treatment, she decided to launch Trusted Canna Nurse with a mission to break stigma through education. Voted a Cannabis Nurse Entrepreneur of the Year by Cannabis Nurses Networks in 2022, Mbengue and her team offer cannabinoid education, consultations, and a line of products for the spectrum of chronic illnesses. In this interview, Mbengue shares how and why she provides guidance as a cannabis nurse for symptoms of conditions such as ADHD, cancer, autism, chronic pain, and more. She also describes the difficulties presented by the lingering stigma of cannabis and explains her hopes for the role of nurses in medical cannabis.

In results from a recent study, respondents reported that cannabis use led them to decrease their use of pharmacological treatments, including opioids.

This study, which evaluated the potential of a well-designed unidirectional aseptic processing approach to both hydrocarbon and supercritical carbon dioxide extract manufacturing, suggests that the extraction process is capable of deactivating or removing the tested microbial contaminants when highly contaminated Cannabis spp. Inflorescence is used as feed material.

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

In the work presented here, the author shares research from collecting reports from the New Jersey State laboratory (the Department of Health’s Environmental and Chemical Laboratory Services), which has conducted testing for the state’s medicinal program. He documented an average variance of 20% in potency levels from different samples of the same test lot.